Currently, there are 52.68M common shares owned by the public and among those 42.22M shares have been available to trade.
The company’s stock has a 5-day price change of -0.16% and 28.29% over the past three months. IMAX shares are trading 68.18% year to date (YTD), with the 12-month market performance up to 68.96% higher. It has a 12-month low price of $13.20 and touched a high of $26.84 over the same period. IMAX has an average intraday trading volume of 635.86K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.30%, 5.01%, and 29.00% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Imax Corp (NYSE: IMAX) shares accounts for 86.56% of the company’s 52.68M shares outstanding.
It has a market capitalization of $1.33B and a beta (3y monthly) value of 1.25. The stock’s trailing 12-month PE ratio is 58.54, while the earnings-per-share (ttm) stands at $0.43. The company has a PEG of 2.76 and a Quick Ratio of 1.17 with the debt-to-equity ratio at 0.99. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.06% over the week and 2.92% over the month.
Earnings per share for the fiscal year are expected to increase by 17.42%, and 16.12% over the next financial year. EPS should grow at an annualized rate of 21.20% over the next five years, compared to 4.87% over the past 5-year period.
Looking at the support for the IMAX, a number of firms have released research notes about the stock. Seaport Research Partners stated their Buy rating for the stock in a research note on July 24, 2024, with the firm’s price target at $23. Barrington Research coverage for the Imax Corp (IMAX) stock in a research note released on April 21, 2023 offered a Outperform rating with a price target of $24. B. Riley Securities was of a view on December 05, 2022 that the stock is Buy, while B. Riley Securities gave the stock Buy rating on October 12, 2022, issuing a price target of $25- $20. Rosenblatt on their part issued Buy rating on May 24, 2022.
